GENE ONLINE|News &
Opinion
Blog

ALS
Asia-Pacific ALS
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27Partner
Trials & Approvals ALS
FDA Rejects BrainStorm Cell Therapeutics’ BLA For ALS Drug
2022-11-11
Trials & Approvals Biogen
FDA Pushes Biogen’s ALS Drug Approval Date Back Three Months
2022-10-18
Trials & Approvals ALS
Amylyx’s ALS Drug Nabs FDA Nod After Rare Regulatory Reversal
2022-09-29
Technology ALS
Insilico Medicine Pinpoints New Targets for ALS With AI
2022-07-08
Trials & Approvals ALS
Canada Approves Amylyx’s Experimental ALS Drug
2022-06-14
Trials & Approvals ALS
Amylyx’s New ALS Drug Review Impeded as FDA Members Disagreed with Clinical Trial Results
2022-04-04
Trials & Approvals Amyotrophic Lateral Sclerosis
Biogen’s ALS Drug Fails to Attain Primary Endpoint but Offers Hope With Secondary Outcomes
2021-10-18
LATEST
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19
Biotech Industry Trends in 2024: A Look at the Billions in Oncology Deals
2024-09-18
Thailand’s Biotech Boom: Innovations in Precision Medicine, Cell Therapy, and Wellness Drive APAC Leadership
2024-09-18
International Green Party Showcases AI Solutions for a Healthy and Sustainable Future
2024-09-16
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
READ MORE
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-10
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top